Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

USANA Health Sciences Updates FY24 Net Sales Outlook From $850M - $920M To $850M - $880M (Est $883.518M) And EPS Outlook From $2.40 - $3.00 To $2.40 - $2.55 (Est $2.78)

Author: Benzinga Newsdesk | July 23, 2024 04:56pm

Posted In: USNA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist